Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Exercise or conversion Chief Medical Officer acquired 9,376 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 2,802 shares (option exercise)
  5. 4 Open-market buy Director bought 36,159 shares at $23.79 ($860,223)
  6. 4 Open-market buy Chief Clinical Dev. Officer bought 2,500 shares at $24.44 ($61,100)
  7. 4 Open-market buy Chief Financial Officer bought 2,500 shares at $19.95 ($49,875)
  8. 4 Open-market buy Director bought 100,000 shares at $20.69 ($2,069,000)
  9. 4 Shares withheld for taxes President and CEO gave up 54,720 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Medical Officer gave up 24,569 shares (to pay taxes)
  11. 4 Exercise or conversion President and CEO acquired 49,460 shares (option exercise)
  12. 4 Shares withheld for taxes Director gave up 4,024 shares (to pay taxes)
  13. 4 Exercise or conversion Director acquired 4,670 shares (option exercise)
  14. 5 Insider Annual Insider Trading Report
  15. 5 Insider Annual Insider Trading Report
  16. 4 Shares withheld for taxes Director gave up 1,746 shares (to pay taxes)
  17. 4 Exercise or conversion President and CEO acquired 2,801 shares (option exercise)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Shares withheld for taxes President and CEO gave up 53,965 shares (to pay taxes)
  20. 4 Exercise or conversion Director acquired 7,472 shares (option exercise)

Page 5 of 30 · 591 filings